PBM Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover and creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any. It relies on appropriations, grants, tax rate changes, and reporting requirements. The main policy areas are Finance, Environment, Healthcare, and Health.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover...
- Creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover and creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any.
Key Policy Areas
Finance, Environment, Healthcare, Health
Primary Purpose
The bill creates findings The Congress finds the following: Pharmacy benefit managers are corporate entities that play a dominant role in pharmaceutical supply chains, determining which drugs health plans will cover and creates prohibitions relating to anticompetitive pharmacy ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control, or direct the operation of the whole or any.
Policy Domains
Sponsors
Legislative Progress
In CommitteeReferred to the House Committee on the Judiciary.
Introduced in House
Mrs. Harshbarger (for herself, Mr. Auchincloss, Mr. Carter of Georgia, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology